Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients

BACKGROUND: Kidney transplantation is the preferred form of kidney replacement therapy for patients with end‐stage kidney disease (ESKD) and is often complicated by worsening or new‐onset diabetes. Management of hyperglycaemia is important to reduce post‐transplant and diabetes‐related complications...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cochrane Database Syst Rev
Päätekijät: Lo, Clement, Jun, Min, Badve, Sunil V, Pilmore, Helen, White, Sarah L, Hawley, Carmel, Cass, Alan, Perkovic, Vlado, Zoungas, Sophia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Ltd 2017
Aiheet:
Medicine General & Introductory Medical Sciences
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464265/
https://ncbi.nlm.nih.gov/pubmed/28238223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009966.pub2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia